Neuropathy symptom and change: Inotersen treatment of hereditary transthyretin amyloidosis.

MLA

Dyck, P.James B., et al. “Neuropathy Symptom and Change: Inotersen Treatment of Hereditary Transthyretin Amyloidosis.” Muscle & Nerve, vol. 62, no. 4, Oct. 2020, pp. 509–15. EBSCOhost, https://doi.org/10.1002/mus.27023.

APA

Dyck, P. J. B., Coelho, T., Waddington Cruz, M., Brannagan, T. H., Khella, S., Karam, C., Berk, J. L., Polydefkis, M. J., Kincaid, J. C., Wiesman, J. F., Litchy, W. J., Mauermann, M. L., Ackermann, E. J., Baker, B. F., Jung, S. W., Guthrie, S., Pollock, M., & Dyck, P. J. (2020). Neuropathy symptom and change: Inotersen treatment of hereditary transthyretin amyloidosis. Muscle & Nerve, 62(4), 509–515. https://doi.org/10.1002/mus.27023

Chicago

Dyck, P. James B., Teresa Coelho, Marcia Waddington Cruz, Thomas H. Brannagan, Sami Khella, Chafic Karam, John L. Berk, et al. 2020. “Neuropathy Symptom and Change: Inotersen Treatment of Hereditary Transthyretin Amyloidosis.” Muscle & Nerve 62 (4): 509–15. doi:10.1002/mus.27023.